These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 15641210

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons.
    Husa P, Husova L.
    Bratisl Lek Listy; 2001; 102(5):248-52. PubMed ID: 11725377
    [Abstract] [Full Text] [Related]

  • 32. [Differential effects of interferon-based treatments in chronic hepatitis C].
    Nakamoto Y, Kaneko S.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):485-7. PubMed ID: 15359846
    [No Abstract] [Full Text] [Related]

  • 33. Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.
    Baek YH, Lee SW, Yoo HS, Yoon HA, Kim JW, Kim YH, Kim HY, Han SY.
    Gut Liver; 2007 Jun; 1(1):87-9. PubMed ID: 20485665
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Development of anti viral therapy for chronic hepatitis type C].
    Hayashi N, Oze T, Hiramatsu N.
    Nihon Rinsho; 2011 May; 69 Suppl 4():173-9. PubMed ID: 22096914
    [No Abstract] [Full Text] [Related]

  • 37. Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.
    Grandini E, Cannoletta F, Scuteri A, Fortini C, Loggi E, Cursaro C, Riili A, Di Donato R, Gramenzi A, Bernardi M, Andreone P.
    Ann N Y Acad Sci; 2010 Apr; 1194():147-52. PubMed ID: 20536463
    [Abstract] [Full Text] [Related]

  • 38. Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study.
    Vega P, Castro A, Hermida M, López Calvo S, Pedreira J.
    Scand J Infect Dis; 1999 Apr; 31(4):359-61. PubMed ID: 10528873
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.